Marius Pharmaceuticals

• Endocrinology
• Hormone Therapies
• Men's Wellness
• Mesotherapy/Hormone Therapies
• Pharmaceuticals
• Urology

Marius Pharmaceuticals is dedicated to improving lives through innovative therapies targeting hypogonadism or Testosterone Deficiency. With a vision to enhance metabolic health and reduce unnecessary healthcare costs globally, Marius Pharmaceuticals is at the forefront of transformative healthcare solutions.

At Marius Pharmaceuticals, the belief is that "Testosterone Deficiency is a Chronic Disease™." This mantra underscores the company's dedication to recognizing and addressing testosterone as an integral component of cardiometabolic health.

In 2022, Marius Pharmaceuticals received FDA approval for KYZATREX®, an oral prescription drug designed to treat adult men with low or no testosterone due to specific medical conditions. This milestone reflects Marius Pharma's commitment to advancing therapeutic options for individuals dealing with testosterone deficiency.

In 2023, Marius Pharmaceuticals launched ReThink Testosterone, a disease state awareness initiative aimed at reshaping the narrative surrounding testosterone and testosterone therapy. ReThink Testosterone empowers men grappling with Low T by delivering essential education and dispelling long-standing myths. Male hypogonadism, or low testosterone, affects millions globally, impacting overall health. However, misconceptions and stigma have hindered understanding and appropriate treatment. ReThink Testosterone is a comprehensive online resource fostering knowledge for informed decision-making about hormonal health. It caters to those experiencing low testosterone and those interested in understanding its implications, facilitating open conversations between patients and healthcare providers.

ReThink Testosterone focuses on dispelling common myths surrounding testosterone therapy. Evidence-based information and expert insights address misconceptions, such as concerns about cardiovascular events, the perception of testosterone solely for sexual and muscular purposes, and unfounded links to aggression. ReThink Testosterone is a reliable resource, refuting myths like claims that testosterone therapy causes prostate cancer, ensuring accurate information is readily available. For more information, visit www.rethinktestosterone.com.

Marius Pharmaceuticals advocates for every man to proactively inquire about their testosterone levels – specifically total testosterone, free testosterone, and sex hormone binding globulin (SHBG). These parameters provide a comprehensive understanding of metabolic health, empowering individuals to take control of their well-being.

For more information on Marius Pharmaceuticals and its transformative initiatives, visit www.mariuspharma.com.